Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 156,079 229,843 273,203 611,547
Total Sell Value $13,472,349 $20,340,408 $24,241,430 $58,103,504
Total People Sold 5 5 6 7
Total Sell Transactions 13 19 25 55
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 1303
  Page 35 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baffi Robert EVP, Technical Operations   •       –      –    2010-05-04 4 GD $0.00 $0 D/D 876 59,712     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-05-03 4 S $22.79 $51,870 D/D (2,275) 20,000     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-05-03 4 OE $11.05 $9,205 D/D 833 22,275     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-04-30 4 A $11.64 $17,827 D/D 1,532 21,387     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-04-30 4 A $11.64 $21,260 D/D 1,827 50,567     -
   Baffi Robert EVP, Technical Operations   •       –      –    2010-04-30 4 A $11.64 $15,744 D/D 1,353 54,540     -
   Davis George Eric SVP, General Counsel   •       –      –    2010-04-30 4 A $11.64 $16,943 D/D 1,456 21,908     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-04-30 4 A $13.23 $19,072 D/D 1,442 21,442     -
   Wood Mark VP, Human Resources   •       –      –    2010-04-12 4 S $23.81 $22,314 D/D (937) 8,081     -
   Wood Mark VP, Human Resources   •       –      –    2010-04-12 4 OE $14.39 $13,483 D/D 937 9,018     -
   Wood Mark VP, Human Resources   •       –      –    2010-04-05 4 S $24.63 $7,684 D/D (312) 8,081     -
   Wood Mark VP, Human Resources   •       –      –    2010-04-05 4 OE $14.00 $4,368 D/D 312 8,393     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-04-01 4 S $24.00 $139,974 D/D (5,833) 20,000     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-04-01 4 OE $11.05 $64,455 D/D 5,833 25,833     -
   Wood Mark VP, Human Resources   •       –      –    2010-03-12 4 S $22.17 $20,793 D/D (938) 8,081     -
   Wood Mark VP, Human Resources   •       –      –    2010-03-12 4 OE $14.39 $13,498 D/D 938 9,019     -
   Baffi Robert EVP, Technical Operations   •       –      –    2010-03-10 4 S $22.52 $3,691,020 D/D (163,888) 60,588     -
   Baffi Robert EVP, Technical Operations   •       –      –    2010-03-10 4 OE $22.00 $3,605,536 D/D 163,888 224,476     -
   Wood Mark VP, Human Resources   •       –      –    2010-03-08 4 S $22.14 $6,930 D/D (313) 8,081     -
   Wood Mark VP, Human Resources   •       –      –    2010-03-08 4 OE $14.00 $4,382 D/D 313 8,394     -
   Klein Joseph III Director   –       •      –    2010-03-08 4 S $22.12 $221,227 D/D (10,000) 35,000     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-03-08 4 S $22.11 $532,526 D/D (24,090) 19,855     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-03-08 4 OE $7.16 $172,484 D/D 24,090 55,361     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-03-05 4 S $21.95 $140,831 D/D (6,416) 43,945     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-03-04 4 S $21.50 $107,500 D/D (5,000) 50,361     -
  1303 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 35 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us